Alpha Pro Tech, Ltd. - 10-K Summary (Fiscal Year Ended Dec 31, 2009)
Business Context and Reporting Period
Company: Alpha Pro Tech, Ltd.
Reporting Period: Fiscal year ended December 31, 2009.
Business Overview: The company develops, manufactures, and markets disposable protective apparel, infection control products, and building supply weatherization products. Operations are organized into three segments: Disposable Protective Apparel, Building Supply, and Infection Control. The company is incorporated in Delaware with executive offices in Markham, Ontario, Canada.
Key Financial Metrics
| Metric | 2009 | 2008 |
|---|---|---|
| Net Sales | $59,697,000 | $35,786,000 |
| Gross Profit | $28,874,000 | $15,480,000 |
| Gross Margin | 48.4% | 43.3% |
| Net Income | $9,041,000 | $1,564,000 |
| Diluted EPS | $0.39 | $0.06 |
| Cash and Equivalents | $9,753,000 | $4,578,000 |
| Working Capital | $28,994,000 | $21,693,000 |
| Long-Term Debt | $0 | $0 |
| Available Credit Facility | $3,500,000 | $3,500,000 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 66.8% to $59.7 million, driven by record sales across all segments.
- Infection Control Surge: Sales in this segment jumped 194.7% to $21.7 million, primarily due to a 283.3% increase in N-95 respirator mask sales linked to the H1N1 Influenza A pandemic.
- Building Supply Expansion: Sales rose 86.1% to $15.3 million, fueled by a 103.6% increase in synthetic roof underlayment sales.
- Profitability: Net income increased 478.1% to $9.0 million. Gross margin improved to 48.4% due to a favorable product mix shift toward higher-margin Infection Control products.
- Expense Increases: Selling, general, and administrative (SG&A) expenses rose 16.3% to $14.7 million, largely due to a $1.26 million increase in executive bonuses tied to pre-tax profits and a $225,000 severance payment.
- Balance Sheet: Cash and cash equivalents increased 113% to $9.8 million. Accounts receivable grew 68.8% to $8.6 million, and inventory increased 8.6% to $13.1 million to support higher sales volumes.
Guidance, Outlook, and Risks
- Outlook: Management expects N-95 respirator mask sales to return to pre-H1N1 levels in 2010 unless pandemic concerns resume. The company anticipates purchasing $1.5 million to $2.0 million of equipment in 2010.
- Capital Allocation: The company does not expect to pay cash dividends. It maintains a share repurchase program with $862,000 remaining available as of year-end.
- Key Risks:
- Customer Concentration: Sales to VWR International, LLC represented 28.7% of total sales in 2009. Loss of this customer would have a material adverse effect.
- Supply Chain: Reliance on subcontractors in Asia and a joint venture in India for manufacturing. Disruptions could delay shipments.
- Economic Conditions: Global recessions could impact demand, particularly in the Building Supply segment.
- Key Personnel: Dependence on CEO Sheldon Hoffman and President Alexander W. Millar.
- Accounting Change: The company changed auditors in July 2009, dismissing PricewaterhouseCoopers LLP and engaging Mayer Hoffman McCann P.C. No disagreements were reported regarding accounting principles.
Investor Verification Checklist
- Verify the sustainability of Infection Control segment margins post-H1N1 pandemic demand.
- Confirm the status of the relationship with VWR International, LLC (28.7% of revenue).
- Monitor the completion and operational impact of the Building Supply facility expansion in Valdosta, Georgia.
- Review the repayment schedule and financial health of the Harmony Plastics joint venture in India.
- Assess the impact of the 2010 equipment capital expenditure plan on cash flow.